Jiangsu Asieris Pharmaceutical Technology Co., Ltd.

For profitWebsite ↗

Also known as: Asieris Pharmaceuticals (AUS) Pty Ltd. | Asieris Pharmaceutical Technologies Co., Ltd. | Jiangsu Yahong Meditech Co.,Ltd. | Jiangsu Yahong Meditech Co., Ltd aka Asieris

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 31, 2018

Last known activity

Feb 20, 2025

Timeline

2010s

Jun 1, 2010
Jiangsu Asieris Pharmaceutical Technology Co., Ltd.— Founded

Drugs by trial phase (7 distinct, 9 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Urinary Bladder Neoplasms

Recent trials (11)

NCT06787950Lead sponsorPhase 1/Phase 2Feb 20, 2025
NCT06435039CollaboratorPhase 1Jun 26, 2024
NCT06435039OfficialPhase 1Jun 26, 2024
NCT06034015Lead sponsorPhase 1Sep 9, 2023
NCT05743010Lead sponsorPhase 1Jan 26, 2023
NCT05743010Study directorPhase 1Jan 26, 2023
NCT05600322CollaboratorPhase 3Oct 31, 2022
NCT04736394Lead sponsorPhase 3Oct 1, 2021
NCT04813107Lead sponsorPhase 1/Phase 2Sep 1, 2021
NCT04601766Lead sponsorPhase 1Oct 21, 2020
NCT03672240Lead sponsorPhase 1/Phase 2Oct 31, 2018

Details

Founded: Shanghai, CN Jun 1, 2010
Last known activity: Feb 20, 2025

Notes

Changed name from "Asieris Pharmaceutical Technologies Co., Ltd." https://asieris.com/company-name-change-announcement/